Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Historical Holders from Q3 2020 to Q3 2025

Symbol
NRIX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
77,143,980
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
84,776,704
Holdings value
$783,330,709
% of all portfolios
0.002%
Number of holders
171
Number of buys
82
Number of sells
-83
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.2% $72,644,381 6,284,116 BlackRock, Inc. 31 Mar 2025
Deep Track Capital, LP 7.21% +35.4% $63,580,000 +$15,895,000 5,500,000 +33.3% Deep Track Capital, LP 31 Mar 2025
FMR LLC 4.1% -61.7% $38,437,849 -$42,758,996 4,159,940 -52.7% FMR LLC 31 Oct 2025
Commodore Capital LP 4.9% -4% $34,927,708 -$646,292 3,780,055 -1.8% Commodore Capital LP 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 4.2% $36,861,858 3,188,742 Wellington Management Group LLP 31 Mar 2025

Institutional Holders of Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 84,776,704 $783,330,709 -$36,480,185 $9.24 171
2025 Q2 88,319,847 $1,005,944,844 +$40,932,248 $11.39 161
2025 Q1 84,604,598 $1,005,122,777 +$28,667,924 $11.88 168
2024 Q4 81,104,522 $1,528,053,172 +$225,677,197 $18.84 173
2024 Q3 67,877,304 $1,525,459,447 +$59,100,303 $22.47 170
2024 Q2 64,996,165 $1,356,466,249 +$340,051,233 $20.87 172
2024 Q1 49,045,600 $720,957,554 +$50,639,301 $14.7 138
2023 Q4 46,078,653 $475,525,962 +$17,732,104 $10.32 127
2023 Q3 44,845,094 $352,482,854 +$8,466,362 $7.86 129
2023 Q2 43,637,466 $435,668,849 +$11,852,256 $9.99 124
2023 Q1 42,478,076 $376,567,538 -$3,101,624 $8.88 121
2022 Q4 42,696,157 $468,798,220 +$2,144,188 $10.98 119
2022 Q3 43,069,388 $561,182,776 -$38,324,545 $13.03 114
2022 Q2 44,940,935 $567,552,048 +$55,435,115 $12.67 100
2022 Q1 40,367,078 $565,503,716 -$19,332,926 $14.01 111
2021 Q4 40,421,865 $1,170,057,078 +$25,875,537 $28.95 121
2021 Q3 39,378,816 $1,180,362,633 -$11,970,711 $29.96 110
2021 Q2 39,520,770 $1,048,795,893 -$66,662,023 $26.53 103
2021 Q1 41,346,108 $1,285,407,277 +$254,357,641 $31.09 99
2020 Q4 33,136,833 $1,089,462,176 +$26,868,033 $32.88 67
2020 Q3 31,854,383 $1,111,189,598 +$1,111,189,598 $34.91 64